Faculty of Science
The Faculty of Science (FNWI), part of Radboud University, engages in groundbreaking research and excellent education. In doing so, we push the boundaries of scientific knowledge and pass that knowledge on to the next generation.
We seek solutions to major societal challenges, such as cybercrime and climate change and work on major scientific challenges, such as those in the quantum world. At the same time, we prepare our students for careers both within and outside the scientific field.
Currently, more than 1,300 colleagues contribute to research and education, some as researchers and lecturers, others as technical and administrative support officers. The faculty has a strong international character with staff from more than 70 countries. Together, we work in an informal, accessible and welcoming environment, with attention and space for personal and professional development for all.
Radboud University
At Radboud University, we aim to make an impact through our work. We achieve this by conducting groundbreaking research, providing high-quality education, offering excellent support, and fostering collaborations within and outside the university. In doing so, we contribute indispensably to a healthy, free world with equal opportunities for all. To accomplish this, we need even more colleagues who, based on their expertise, are willing to search for answers. We advocate for an inclusive community and welcome employees with diverse backgrounds, cultures, and perspectives. Will you also contribute to making the world a little better? You have a part to play.
If you want to learn more about working at Radboud University, follow our Instagram account and read stories from our colleagues.
Do you want to study the role of protein regulatory networks in the context of cancer? As a PhD Candidate at the Vermeulen Lab, you will develop and apply innovative omics strategies.
Protein–protein interactions and dynamic protein states are important for cellular identity. Aberrations in proteins drive oncogenic signalling and disease progression. The goal of the Oncode Accelerator Growth Fund project is to accelerate the development of new cancer therapies. In this PhD project, you will employ existing proteomic tools and develop new ones to study protein interactions and signalling pathways in primary cancer tissues, organoids and clinical samples. A key aim is to connect molecular mechanisms to tumour biology and identify novel actionable targets for drug development.
You will work extensively with patient-derived FFPE material, which is readily available within our clinical network. You will optimise and implement proteomic workflows tailored for highly limited, heterogeneous samples, enabling in-depth profiling of tumour biology. A major component of your work will be to establish intratumoral heterogeneity maps using spatial proteomic profiling, including the use of laser capture microdissection to isolate defined tumour regions prior to mass spectrometry analysis. Where feasible, you will also explore single-cell proteomics approaches on patient samples to gain additional resolution on cell-state diversity within tumours.
In parallel, you will collaborate closely with a postdoctoral researcher to develop and apply novel proximity-labelling strategies to chart dynamic protein–protein interactions and local proteome environments. These methodological developments will feed directly into large-scale interaction and signalling network analyses across clinically annotated cohorts.
Together, these efforts will generate an unprecedented, high-resolution view of how cancer-specific protein interaction networks are rewired in human disease. The project’s findings are expected to inform new hypotheses on epigenetic control in cancer and contribute to Oncode Accelerator’s translational goals of identifying actionable molecular targets.
Your teaching load may be up to 10% of your working time.
Would you like to learn more about what it’s like to pursue a PhD at Radboud University? Visit the page about working as a PhD candidate.
The Vermeulen Lab specialises in the development and application of state-of-the-art (interaction) proteomics technologies to understand how proteins and protein networks regulate gene expression and cell fate in health and disease. You will join a dynamic and internationally recognised research group that combines various mass spectrometry-based techniques to address fundamental biological questions. As part of the Oncode Accelerator consortium, you will collaborate closely with affiliated groups across the Netherlands, and you will have access to clinical material and expertise in translational cancer research. You will also have ample opportunities to establish connections with various pharmaceutical companies.
You can apply only via the button below. Address your letter of application to Michiel Vermeulen. In the application form, you will find which documents you need to include with your application. We look forward to receiving your application.
The first interviews will take place on 23 January. Any second interview will take place on 12 February. You will preferably start your employment as soon as possible.
We can imagine you're curious about our application procedure. It describes what you can expect during the application procedure and how we handle your personal data and internal and external candidates.
| Type of employment | Temporary position |
|---|---|
| Employment expires | 2027-07-14 |
| Contract type | Full time |
| First day of employment | 15-01-2026 |
| Salary | Promovendus (P) |
| Salary |
|
| Number of positions | 1 |
| Full-time equivalent | 1,0 |
| City | Nijmegen |
| County | Gelderland |
| Country | Netherlands |
| Reference number | 62.175.25 |
| Published | 02.Dec.2025 |
| Last application date | 04.Jan.2026 |